Successful treatment of amiodarone-induced thyrotoxicosis type 1 in combination with methimazole and potassium iodide in a patient with Hashimoto's thyroiditis

1Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

A patient with underlying Hashimoto's thyroiditis developed amiodarone-induced thyrotoxicosis type 1 that was successfully treated using methimazole in combination with potassium iodide. A 35-year-old woman admitted for perinatal care of twin-to-twin transfusion syndrome was given amiodarone for 7 days for paroxysmal ventricular contraction following pulseless ventricular tachycardia 1 day after delivery. She developed thyrotoxicosis one month after the discontinuation of amiodarone therapy and was negative for thyroidstimulating hormone receptor antibody. An increased peak velocity of the superior thyroid artery suggested amiodarone-induced thyrotoxicosis type 1. Her thyroid function recovered after combination therapy with methimazole and potassium iodide.

Cite

CITATION STYLE

APA

Katoh, D., Yoshino, H., Ikehara, K., Kumashiro, N., Uchino, H., Tsuboi, K., & Hirose, T. (2020). Successful treatment of amiodarone-induced thyrotoxicosis type 1 in combination with methimazole and potassium iodide in a patient with Hashimoto’s thyroiditis. Internal Medicine, 59(3), 383–388. https://doi.org/10.2169/internalmedicine.2179-18

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free